LY75-CD302 p.Ser1840Pro
c.5518T>C · VCV3292355
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0867 | likely benign |
|---|---|---|
| REVEL | 0.094 | moderately benign-leaning |
| SaProt | LLR -12.21 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense and REVEL do not. | ||
| Splicing | ||
| SpliceAI | — | not looked up on this page · why |
| Constraint at this position | ||
| Conservation | phyloP 3 | GERP 1.7, phastCons 0.89 |
| Overall | ||
| CADD | 19.48 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM S199P vs ClinVar S1840P) — verify the residue.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- LY75-CD302
- Protein
- p.Ser1840Pro
- Coding
- c.5518T>C
- MANE Select
- NM_014880 · reported on NM_001198759
- Type
- single nucleotide variant
- Location
- chr2:159771955 (GRCh38)
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ly75-cd302-p-ser1840pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown